Stay updated on Relamorelin in Diabetic Gastroparesis Clinical Trial

Sign up to get notified when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relamorelin in Diabetic Gastroparesis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the Notice about lapse in government funding and the older Revision: v3.4.1. These are administrative updates and do not affect the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T14:26:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, noting that information may not be up to date and inquiries may be delayed, and directing users to cc.nih.gov and opm.gov. Updated the version to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:40:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and updated labels to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0,' while removing the older 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' items with minor capitalization changes. These changes are cosmetic UI updates and do not alter study data or its results.
    Difference
    0.1%
    Check dated 2026-01-28T06:21:45.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a backend revision update from v3.3.3 to v3.3.4, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:05:55.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A consolidated Locations section listing study sites across numerous states and Scotland has been added; per-state location headers have been removed and the HHS Vulnerability Disclosure link was deleted.
    Difference
    2%
    Check dated 2025-12-23T20:43:06.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Both additions and deletions are minor wording changes: they clarify how PubMed publications are populated and update the revision label, without altering study content, endpoints, or participant-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:34:28.000Z thumbnail image

Stay in the know with updates to Relamorelin in Diabetic Gastroparesis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relamorelin in Diabetic Gastroparesis Clinical Trial page.